Dosing underway in LAVA Therapeutics' Phase 1/2a trial of LAVA-051 for multiple hematological malignancies
13 July 2021 - 9:44PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
LAVA Therapeutics NV (NASDAQ:LVTX)
Historical Stock Chart
From Apr 2024 to May 2024
LAVA Therapeutics NV (NASDAQ:LVTX)
Historical Stock Chart
From May 2023 to May 2024